Skip to main content
. 2007 Sep;1(5):639–644. doi: 10.1177/193229680700100507

Figure 1.

Figure 1.

In vitro system used to evaluate CGMS delays. A CGMS sensor was placed in phosphate buffer, and infusion pumps with 20% glucose or buffer were used to manipulate the glucose level. A pipette was used to obtain samples that were measured with a YSI glucose analyzer (not shown), and a CGM system (shown on right) was used to obtain the sensor glucose profile.

HHS Vulnerability Disclosure